Jan 2004

FDA Approves Pfizer's Caduet to Lower Hypertension

This event has not been added to any topics.

Caduet combines the drugs amlodipine (Norvasc, Lotrel) and atorvastatin (Lipitor), two widely prescribed cardiovascular medications. It's the first medicine to treat two different conditions, high blood pressure and high cholesterol.
It is indicated for the treatment of hypertension, chronic stable angina and vasospastic angina (Prinzmetal’s or variant angina). It is also indicated for primary dysbetalipoproteinemia, elevated serum TG levels, hypercholesterolemia and mixed dyslipidemia. In addition, is indicated as an adjunct to diet to reduce total-C, LDL-C, and apo B levels in boys and postmenarchal girls, 10 to 17 years of age, with heterozygous familial hypercholesterolemia
The recommened initial antihypertensive oral dose of amlodipine is 5 mg once daily with a maximum dose of 10 mg once daily.

http://www.centerwatch.com/drug-information/fda...

Source/Attribution

Center Watch

Added Tue, Jun 1 2010 at 6:11PM UTC by

Carla Friedman

Be the First to Comment on this Description

You must log in or register to comment.